Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) received some bad news last week after its oral multiple sclerosis drug laquinimod received a negative opinion by the EU’s CHMP. In this video, Motley Fool health-care analyst Max Macaluso takes a look at what this decision means for Teva, and where the company needs to strategically go from here following this decision. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $45.09 in last session, and closed at $44.63, while the day range of TEVA stock is $44.53 – $45.22. The stock showed a positive weekly performance of 3.96%.
Dynavax Technologies Corporation (NASDAQ: DVAX) announced that it will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16, 2014 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time) Dynavax Technologies Corporation (NASDAQ:DVAX) stock opened at $1.74, in last session and closed at $1.74, by losing -1.14%. The 52 week range of DVAX is $0.98 – $3.33. Company’s market capitalization is $456.97million.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) climbed 20.53%, scoring 12th gain in a row, as the company is conducting simultaneous phase II studies of its experimental drug PBT2 in Huntington’s disease and Alzheimer’s disease. The results from the Alzheimer’s study are expected in March, but the outcome of the Huntington’s study should be made public first and the exact forecast from Prana is early 2014. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock decreased -5.92% and finished the last session at $11.60. The EPS of the stock remained -0.20. Company’s market capitalization is $472.59million.
Allergan Inc. (NYSE:AGN) based in Irvine, Calif., is a Zacks Rank #2 (Buy) stock with an Earnings ESP of +0.75%. The Zacks Consensus Estimate for the fourth quarter is $1.34. Allergan, Inc. (NYSE:AGN) stock opened the session at $113.68, and closed the session at $114.60. The 52 week range of the AGN stock remained $81.33 – $123.83 and the day range was $112.92 – $115.84.